BIOLASE Begins Strategic Partnership to Enter ENT Laser Market
(firmenpresse) - IRVINE, CA -- (Marketwired) -- 07/25/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, and a pioneer in laser surgery in other medical specialties, announced today that it has entered into a strategic agreement with Valam Corporation ("Valam") to develop, market, and sell office-based laser systems to otolaryngologists (also known as "Ear, Nose, and Throat" or "ENT" doctors). The agreement provides BIOLASE® with an ENT laser patent portfolio, plus the know-how and marketing support of Dr. Yosef Krespi, one of the world's leading authorities on the use of lasers for the surgical treatment sinusitis, sleep apnea, and office-based laser procedures. BIOLASE's EPIC™ 10 soft-tissue laser has already been cleared by the U.S. Food and Drug Administration (the "FDA") for use in ENT surgical procedures.
Dr. Krespi is Clinical Professor of Otolaryngology at Columbia University and founding member of the New York Head & Neck Institute, where he also chairs the Sleep Disorders Center. Valam has been the vehicle over the years for him to place his innovations in ENT laser concepts, including lasers for sinusitis, laser microbial killing / biofilm disruption, and the use of lasers for treating halitosis. "The Valam team is very excited about this strategic relationship, we could not think of a better corporate partner than BIOLASE to launch laser products that are the culmination of years of ENT-specific surgical laser research and development," said Dr. Krespi of Valam.
Federico Pignatelli, Chairman and Chief Executive Officer of BIOLASE, said, "We look forward to being able to offer an elegant, simple-to-use, precision laser-based biologic cutting tool to the 9,000 practicing otolaryngologists in the United States. BIOLASE has planned to enter the ENT market with a clinical laser product offering. Valam and Dr. Krespi give us the opportunity to enter the ENT space with a robust product and a thought-leader in the field as our initial spokesperson and product champion."
"Our partnership with Valam includes an exclusive worldwide license to all of Valam's ENT-related patents and pending patents, which when combined with BIOLASE's existing ENT laser-related patents, creates a formidable patent estate," said Alexander K. Arrow, MD, President and Chief Operating Officer of BIOLASE. "BIOLASE plans to hire a small specialized ENT sales force in advance of our ENT launch, which could occur as soon as the fourth quarter of this year."
About Valam Corporation
Valam Corporation was founded in 2005, by Yosef Krespi, M.D., F.A.C.S. to pursue light and laser based antimicrobial and biofilm destruction therapies. Valam is headquartered in New York, NY, with technology development facilities in Europe and Israel. Valam has built a strong and internationally recognized board of directors and a team of medical, scientific and technical experts who are committed to its success.
About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and . The Company's proprietary laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaginative products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers. Other laser products under development address ophthalmology and other medical and consumer markets.
For updates and information on WaterLase and laser dentistry, find BIOLASE online at , Facebook at , Twitter at , Pinterest at , LinkedIn at , Instagram at and YouTube at .
BIOLASE®, WaterLase®, and EPIC™ are registered trademarks or trademarks of BIOLASE, Inc.
For further information, please contact:
Michael Porter
Porter, LeVay & Rose, Inc.
212-564-4700
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 25.07.2013 - 13:00 Uhr
Sprache: Deutsch
News-ID 281794
Anzahl Zeichen: 0
contact information:
Town:
IRVINE, CA
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 255 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BIOLASE Begins Strategic Partnership to Enter ENT Laser Market"
steht unter der journalistisch-redaktionellen Verantwortung von
BIOLASE, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
